Online citations, reference lists, and bibliographies.

Desquamative Inflammatory Vaginitis.

O. Reichman, J. Sobel
Published 2014 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Desquamative inflammatory vaginitis (DIV) is an uncommon form of chronic purulent vaginitis. It occurs mainly in Caucasians with a peak occurrence in the perimenopause. Symptoms and signs are nonspecific; DIV is a diagnosis of exclusion, and other causes of purulent vaginitis should be excluded. The main symptoms include purulent discharge, vestibulo-vaginal irritation, and dyspareunia. Examination of vaginal walls shows signs of inflammation with increased erythema and petechiae. Through microscopy (wet mount) of the vaginal secretions, DIV is defined by an increase in inflammatory cells and parabasal epithelial cells (immature squamous cells). Vaginal flora is abnormal and pH is always elevated above 4.5. Although etiology and pathogenesis remain unknown, the favorable response to anti-inflammatory agents suggests that the etiology is immune mediated. Either local vaginal clindamycin or vaginal corticosteroids are adequate treatment. As a chronic condition, maintenance treatment should be considered as relapse is common.
This paper references
10.1007/s00404-011-1861-6
Group A streptococcal vaginitis: an unrecognized cause of vaginal symptoms in adult women
Hans Verstraelen (2011)
Desquamative inflammatory vaginitis as a manifestation of vitamin D deficiency associated with Crohn disease: case reports and review of the literature.
Monica Peacocke (2010)
10.1016/0002-9378(65)90113-4
VAGINITIS IN WOMEN, DIAGNOSIS AND TREATMENT.
L. Gray (1965)
10.1016/S0002-9378(16)37537-8
An unusual case of exudative vaginitis (hydrorrhea vaginalis) treated with local hydrocortisone.
L. C. Scheffey (1956)
10.3122/15572625-13-3-178
Impact of Vaginal Antifungal Products on Utilization of Health Care Services: Evidence from Physician Visits
M. Lipsky (2000)
10.1007/s11908-010-0135-y
Clinical Spectrum of Desquamative Inflammatory Vaginitis
C. Stockdale (2010)
10.1016/0002-9378(94)90135-X
Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2% clindamycin therapy.
J. Sobel (1994)
Desquamative in fl ammatory vaginitis
TR Hannon
Treatment of desquamative inflammatory vaginitis with vitamin D: a case report.
Monica Peacocke (2008)
10.1038/35101544
Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria
F. Schluenzen (2001)
10.1016/S0002-9378(16)34306-X
Desquamative inflammatory vaginitis.
T. Hannon (1969)
10.1093/infdis/149.3.471
Clindamycin-induced suppression of toxic-shock syndrome--associated exotoxin production.
P. Schlievert (1984)
10.1016/0002-9378(68)90399-2
Desquamative inflammatory vaginitis: a newly defined entity.
H. Gardner (1968)
10.1001/JAMA.291.11.1368
Evaluation of vaginal complaints.
M. Anderson (2004)
10.1097/LGT.0b013e3181dc2f6a
Papular Colpitis: A Distinct Clinical Entity?: Symptoms, Signs, Histopathological Diagnosis, and Treatment in a Series of Patients Seen at the Rotterdam Vulvar Clinic
W. I. van der Meijden (2011)
Sobel JD . Desquamative in fl ammatory vaginitis : an exploratory case - control study
EC Newbern (2002)
Desquamative in fl ammatory vaginitis : what is it ?
R Murphy
10.1111/j.1396-0296.2004.04006.x
Desquamative inflammatory vaginitis
R. Murphy (2008)
10.1136/sti.66.4.275
Desquamative inflammatory vaginitis. A review.
J. Oates (1990)
10.1016/J.AMJMED.2004.07.025
Clinical implications of the immunomodulatory effects of macrolides on sinusitis.
Y. Majima (2004)
Chronic inflammation of the vagina: treatment and relationship to autoimmunity.
John C. Thomson (2005)
10.1097/LGT.0b013e3181d737d0
Desquamative Inflammatory Vaginitis: Differential Diagnosis and Alternate Diagnostic Criteria
Jennifer Bradford (2010)
10.1111/j.1471-0528.2002.00432.x
Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis
G. Donders (2002)
10.1016/S1047-2797(01)00316-7
Desquamative inflammatory vaginitis: an exploratory case-control study.
E. Newbern (2002)
10.1111/1523-1747.ep12543487
The effect of antimicrobial agents on leukocyte chemotaxis.
N. Esterly (1978)
10.1097/LGT.0b013e31822a198d
Chronic Vulvovaginitis in Women Older Than 50 Years: Analysis of a Prospective Database
P. Nyirjesy (2012)
10.1159/000017846
An Overview of Topical Antibiotics for Acne Treatment
M. Toyoda (1998)
Prognosis and treatment of desquamative in fl ammatory vaginitis
JD Sobel (2011)
10.1093/JAC/DKH519
Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
G. Amsden (2005)
10.1097/LGT.0b013e3182656991
Vaginal Toxic Shock Reaction Triggering Desquamative Inflammatory Vaginitis
N. Pereira (2013)
Desquamative inflammatory vaginitis. A case report.
M. Jacobson (1989)
10.1016/j.det.2010.07.004
Dermatologic causes of vaginitis: a clinical review.
Libby Edwards (2010)
Desquamative in fl ammatory vaginitis : a newly de fi ned entity
HL Gardner (1968)
10.1097/01.AOG.0000239103.67452.1a
Causes of Chronic Vaginitis: Analysis of a Prospective Database of Affected Women
P. Nyirjesy (2006)
10.1515/BC.2008.069
A potential role for tissue kallikrein-related peptidases in human cervico-vaginal physiology
J. Shaw (2008)
10.1097/AOG.0b013e3182117c9e
Prognosis and Treatment of Desquamative Inflammatory Vaginitis
Jack D. Sobel (2011)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar